Better understanding of how colon cancer develops and progresses

September 11, 2018, University of Luxembourg
Cancer cells. Credit: Dr. Cecil Fox, National Cancer Institute

Researchers from the University of Luxembourg have discovered a molecular mechanism that is responsible for the spread of cancer cells in the body and the development of metastases in patients with colon cancer. Their findings could help to develop treatments that inhibit tumor growth.

Colorectal cancer (CRC) is among the most prevalent cancer types worldwide, with an estimated 1.3 million new cases and almost 700,000 deaths per year. The vast majority of CRC-related deaths can be attributed to metastatic spreading of the disease. Therefore, it is of utmost clinical relevance to understand the biology that underlies cancer progression and metastasis initiation.

First step for the development of novel therapeutic strategies

The scientists from the Molecular Disease Mechanisms (MDM) group at the University of Luxembourg compared cancer cells derived from primary, i.e. initial, tumors to from the same patient. The researchers found that a group of small molecules, namely the miR-371~373 cluster, is responsible for the regulation of metastasis. In an interdisciplinary approach, combining experimental and computational analyses, the research team observed that the miR-371~373 cluster is deactivated in a specific population of very aggressive, fast-growing . After the scientists reactivated the cluster in a complex series of experiments, the growth of the metastatic cells slowed down significantly. "Cancer is a really complex disease. While our results are just one piece of the puzzle, they clearly contribute to a better understanding of tumor initiation and metastasis and might be an important first step for the development of novel therapeutic strategies," said Dr. Pit Ullmann, the lead author of the study that was published in the prestigious journal Cancer Research.

Together with national and international collaborators from the RWTH University Hospital Aachen, the Integrated BioBank of Luxembourg (IBBL), the Centre d"Investigation et d'Épidémiologie Clinique (CIEC), the Laboratoire National de Santé (LNS), and several hospitals around the country, especially the Centre Hospitalier Emile Mayrisch (CHEM), the researchers were able to validate their results in patient samples from a large Luxembourgish colon cancer collection. "This kind of study is only possible if several groups with different expertise collaborate. Our partners have been very important throughout the project in order to assess the clinical relevance of our findings in patients," commented Dr. Elisabeth Letellier, principal investigator of the study.

The large study was supported by the Luxembourg National Research Fund (FNR) and the Fondation Cancer. "Competitive research heavily relies on state-of-the-art techniques and the availability of high quality patient samples. The concerted effort of different groups, the interdisciplinary approach, and especially the financial support by the FNR, the Fondation Cancer, and other funding institutions were crucial for the successful completion of this project," said Prof. Serge Haan, the head of the MDM group.

Explore further: New biomarkers for colorectal cancer

More information: Pit Ullmann et al. The miR-371∼373 Cluster Represses Colon Cancer Initiation and Metastatic Colonization by Inhibiting the TGFBR2/ID1 Signaling Axis, Cancer Research (2018). DOI: 10.1158/0008-5472.CAN-17-3003

Related Stories

New biomarkers for colorectal cancer

January 11, 2018
For colorectal cancer (CRC), early detection and classification is important, as not all Stage II patients benefit from chemotherapy. Identifying patients at risk for recurrence during the early course of the disease might ...

New clues for the early detection of colorectal cancer

October 9, 2014
Researchers at the University of Luxembourg have identified potential new ways to test for the first signs of one of the most deadly types of cancer: colorectal cancer. They have found new "biomarkers": molecules whose increased ...

Scientists shed light on a tumor-suppressive protein in metastases

December 6, 2017
A new study conducted at the VIB-KU Leuven Center for Cancer Biology in Belgium has labeled the protein Caveolin-1 as a high-potential target in the fight against cancer. Many research projects have already implicated this ...

Targeting molecules called miR-200s and ADAR2 could prevent tumor metastasis in patients with colorectal cancer

April 24, 2018
Colorectal cancer is the third most common cancer worldwide and the third-leading cause of cancer-related deaths. The main cause of death in patients with colorectal cancer is liver metastasis, with nearly 70% of patients ...

Gene thought to suppress cancer may actually promote spread of colorectal cancer

January 4, 2016
A gene that is known to suppress the growth and spread of many types of cancer has the opposite effect in some forms of colorectal cancer, University of Missouri School of Medicine researchers have found. It is a finding ...

Researchers identify specific protein that helps breast cancer to spread

January 25, 2018
Researchers from the University's Institute of Translational Medicine have found an explanation for how breast cancer spreads to the lungs, which could potentially hold the key to preventing the progression of the disease.

Recommended for you

Treatment shown to improve the odds against bone marrow cancer

December 15, 2018
Hope has emerged for patients with a serious type of bone marrow cancer as new research into a therapeutic drug has revealed improved outcomes and survival rates.

Immunotherapy combo not approved for advanced kidney cancer patients on the NHS

December 14, 2018
People with a certain type of advanced kidney cancer will not be able to have a combination of two immunotherapy drugs on the NHS in England.

New drug seeks receptors in sarcoma cells, attacks tumors in animal trials

December 13, 2018
A new compound that targets a receptor within sarcoma cancer cells shrank tumors and hampered their ability to spread in mice and pigs, a study from researchers at the University of Illinois reports.

Surgery unnecessary for many prostate cancer patients

December 13, 2018
Otherwise healthy men with advanced prostate cancer may benefit greatly from surgery, but many with this diagnosis have no need for it. These conclusions were reached by researchers after following a large group of Scandinavian ...

Lethal combination: Drug cocktail turns off the juice to cancer cells

December 12, 2018
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth—this was discovered by researchers from the University of Basel's Biozentrum two years ago. In a follow-up study, ...

Combining three treatment strategies may significantly improve melanoma treatment

December 12, 2018
A study by a team led by a Massachusetts General Hospital (MGH) investigator finds evidence that combining three advanced treatment strategies for malignant melanoma—molecular targeted therapy, immune checkpoint blockade ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.